Leone, Robert D.
Powell, Jonathan D. http://orcid.org/0000-0002-0850-2852
Article History
Accepted: 18 May 2020
First Online: 6 July 2020
Competing interests
: J.D.P. is a scientific founder, a paid consultant and has equity in Dracen Pharmaceuticals. Technology arising in part from the studies described herein was patented by Johns Hopkins University and subsequently licensed to Dracen Pharmaceuticals (JHU083 is currently labelled as DRP-083). R.D.L. and J.D.P. are inventors for pending patent application no. PCT/US16/44829 submitted by Johns Hopkins University that covers the use of glutamine analogues, such as JHU083 (DRP-083), for cancer immunotherapy. J.D.P has been a paid consultant for Corvus Pharmaceuticals and has equity in the company.